X0306 4 2017-02-08 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2017-02-08 4 A 0 8223.0000 0.0000 A 29830.0826 D Common Stock 2017-02-08 4 A 0 3194.0000 0.0000 A 33024.0826 D Common Stock 2017-02-08 4 A 0 1641.0000 235.4900 A 34665.0826 D Common Stock 2017-02-08 4 A 0 703.0000 164.8430 A 35368.0826 D Common Stock 2017-02-08 4 F 0 4004.0000 236.6800 D 31364.0826 D Common Stock 2017-02-09 4 S 0 5816.0000 239.5782 D 25548.0826 D Common Stock 73.6530 I 401(k) Plan Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from November 8, 2016 to February 6, 2017. Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019. Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $239.49 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 2.321 shares acquired under the Company's 401(k) Plan from November 5, 2016 to February 3, 2017. Myra McGinley, Attorney-in-Fact 2017-02-10